Susquehanna International Group
BNR

Susquehanna International Group’s Burning Rock Biotech BNR Stock Holding History

Susquehanna International Group’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,908
Closed -$13.9K – 12066
2024
Q1 		$13.9K Buy
+1,908
New +$15.9K ﹤0.01% 11880
2023
Q1 		– Sell
-6,593
Closed -$148K – 12584
2022
Q4 		$148K Buy
+6,593
New +$150K ﹤0.01% 10508

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's BNR Position: Q2 2024 in Review

Susquehanna International Group sold out of Burning Rock Biotech (BNR) in Q2 2024, closing a stake of 1,908 shares — an estimated $13.9K sold.

Susquehanna International Group first reported a position in BNR in Q4 2022 and held it in 2 quarters. The position peaked at $148K in Q4 2022. 18 funds tracked by Wall St. Rank hold BNR as of Q2 2024.

  • Susquehanna International Group reported no remaining Burning Rock Biotech position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 1,908 Burning Rock Biotech shares in Q2 2024, an estimated $13.9K.
  • Susquehanna International Group first reported a position in Burning Rock Biotech in Q4 2022 and held it in 2 quarters.
  • Susquehanna International Group's Burning Rock Biotech position peaked at $148K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.